Abstract: The present invention provides compositions and methods for treating insulin-dependent diabetes mellitus in a subject comprising administration of a self-vector encoding and expressing human proinsulin.
Type:
Application
Filed:
November 21, 2018
Publication date:
October 17, 2019
Applicant:
Tolerion, Inc.
Inventors:
Bart O. Roep, William H. Robinson, Paul Utz, Hideki Garren, Lawrence Steinman